{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:10:58Z","timestamp":1790698258628,"version":"4.1.0"},"reference-count":324,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Congenital and perinatal infections are transmitted from mother to infant during pregnancy across the placenta or during delivery. These infections not only cause pregnancy complications and still birth, but also result in an array of pediatric morbidities caused by physical deformities, neurodevelopmental delays, and impaired vision, mobility and hearing. Due to the burden of these conditions, congenital and perinatal infections may result in lifelong disability and profoundly impact an individual's ability to live to their fullest capacity. While there are vaccines to prevent congenital and perinatal rubella, varicella, and hepatitis B infections, many more are currently in development at various stages of progress. The spectrum of our efforts to understand and address these infections includes observational studies of natural history of disease, epidemiological evaluation of risk factors, immunogen design, preclinical research of protective immunity in animal models, and evaluation of promising candidates in vaccine trials. In this review we summarize this progress in vaccine development research for Cytomegalovirus, Group B Streptococcus, Herpes simplex virus, Human Immunodeficiency Virus, Toxoplasma, Syphilis, and Zika virus congenital and perinatal infections. We then synthesize this evidence to examine how close we are to developing a vaccine for these infections, and highlight areas where research is still needed.<\/jats:p>","DOI":"10.3389\/fped.2020.00569","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T19:06:11Z","timestamp":1610305571000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Vaccines for Perinatal and Congenital Infections\u2014How Close Are We?"],"prefix":"10.3389","volume":"8","author":[{"given":"Tulika","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"B1","unstructured":"GenevaWorld Health OrganizationReport on Global Sexually Transmitted Infection Surveillance2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0211720","DOI":"10.1371\/journal.pone.0211720","article-title":"Global burden of maternal and congenital syphilis and associated adverse birth outcomes\u2014estimates for 2016 and progress since 2012","volume":"14","author":"Korenromp","year":"2019","journal-title":"PLoS ONE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3109\/14767058.2016.1169526","article-title":"Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature","volume":"30","author":"Yazigi","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B4","unstructured":"Prevention of measles, rubella, congenital rubella syndrome, and mumps. 2013: summary recommendations of the advisory committee on immunization practices (ACIP)134 McLeanHQ FiebelkornAP TemteJL WallaceGS 23760231MMWR Recommend Rep622013"},{"key":"B5","volume-title":"Plotkin's Vaccines","author":"Plotkin","year":"2017"},{"key":"B6","unstructured":"Rubella in Pregnant Women, and Surveillance for Congenital Rubella Syndrome.2019"},{"key":"B7","unstructured":"Immunization Coverage2019"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recommend Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.vaccine.2017.07.046","article-title":"Hepatitis B vaccines: WHO position paper \u2013 July 2017","volume":"92","author":"WHO","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"B10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/14651858.CD004790.pub2","article-title":"Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis","volume":"332","author":"Lee","year":"2006","journal-title":"BMJ"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1141","DOI":"10.1542\/peds.2014-3213","article-title":"Outcomes of infants born to women infected with hepatitis B","volume":"135","author":"Schillie","year":"2015","journal-title":"Pediatrics."},{"key":"B12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1542\/peds.76.5.713","article-title":"Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial","volume":"76","author":"Xu","year":"1985","journal-title":"Pediatrics."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1001\/jama.1985.03350360066020","article-title":"Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization","volume":"253","author":"Stevens","year":"1985","journal-title":"JAMA."},{"key":"B14","unstructured":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)140 MarinM G\u00fcrisD ChavesSS SchmidS SewardJF 17585291MMW Recommend Rep.562007"},{"key":"B15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0891-5520(05)70313-5","article-title":"The epidemiology of varicella-zoster virus infections","volume":"10","author":"Wharton","year":"1996","journal-title":"Infect Dis Clin North Am."},{"key":"B16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/sj.jp.7200457","article-title":"The congenital varicella syndrome","volume":"20","author":"Sauerbrei","year":"2000","journal-title":"J Perinatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1111\/ajt.12477","article-title":"Updated recommendations for use of VariZIG - United States","volume":"13","author":"Marin","year":"2013","journal-title":"Am J Transpl"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0217749","DOI":"10.1371\/journal.pone.0217749","article-title":"Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, infants: varicella outcomes safety results from a large, open-label, expended-access program","volume":"14","author":"Levin","year":"2019","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/14760584.2017.1343669","article-title":"Varicella vaccination - the global experience","volume":"16","author":"Wutzler","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B20","doi-asserted-by":"publisher","first-page":"w14526","DOI":"10.4414\/smw.2017.14526","article-title":"Review of maternal immunisation during pregnancy: focus on pertussis and influenza","volume":"147","author":"Blanchard-Rohner","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"B21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/bdra.23547","article-title":"Maternal immunization","volume":"109","author":"Chu","year":"2017","journal-title":"Birth Defects Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/j.jinf.2016.04.027","article-title":"Maternal immunization: optimizing protection for the mother and infant","volume":"72","author":"Kachikis","year":"2016","journal-title":"J Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/AOG.0000000000000581","article-title":"Vaccinations for pregnant women","volume":"125","author":"Swamy","year":"2015","journal-title":"Obstet Gynecol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4049\/immunohorizons.1700057","article-title":"The impact of IgG transplacental transfer on early life immunity","volume":"2","author":"Fouda","year":"2018","journal-title":"ImmunoHorizons."},{"key":"B25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","article-title":"Evolution of maternofetal transport of immunoglobulins during human pregnancy","volume":"36","author":"Malek","year":"1996","journal-title":"Am J Reprod Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1007161","DOI":"10.1371\/journal.ppat.1007161","article-title":"Noncanonical placental Fc receptors: what is their role in modulating transplacental transfer of maternal IgG?","volume":"14","author":"Martinez","year":"2018","journal-title":"PLoS Pathog."},{"key":"B27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1651-2227.1998.tb00972.x","article-title":"Placental transfer favours high avidity IgG antibodies","volume":"87","author":"Avanzini","year":"1998","journal-title":"Acta Paediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1128\/CDLI.1.6.667-669.1994","article-title":"Placental transfer of immunoglobulin G subclasses","volume":"1","author":"Garty","year":"1994","journal-title":"Clin Diagn Lab Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cell.2019.05.044","article-title":"Fc Glycan-mediated regulation of placental antibody transfer","volume":"178","author":"Jennewein","year":"2019","journal-title":"Cell."},{"key":"B31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cell.2019.05.046","article-title":"Fc characteristics mediate selective placental transfer of IgG in HIV-infected women","volume":"178","author":"Martinez","year":"2019","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0150100","DOI":"10.1371\/journal.pone.0150100","article-title":"Association of maternal immunity with rotavirus vaccine immunogenicity in zambian infants","volume":"11","author":"Chilengi","year":"2016","journal-title":"PLoS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.vaccine.2013.11.104","article-title":"The relationship between concentration of specific antibody at birth and subsequent response to primary immunization","volume":"32","author":"Jones","year":"2014","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1128\/JVI.62.10.3907-3910.1988","article-title":"Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses","volume":"62","author":"Murphy","year":"1988","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/cid\/ciu354","article-title":"Measles vaccination in the presence or absence of maternal measles antibody: Impact on child survival","volume":"59","author":"Aaby","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00006454-199503000-00007","article-title":"Serologic status and measles attack rates among vaccinated and unvaccinated children in rural senegal","volume":"14","author":"Samb","year":"1995","journal-title":"Pediatr Infect Dis J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.vaccine.2013.12.017","article-title":"Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants","volume":"32","author":"Appaiahgari","year":"2014","journal-title":"Vaccine."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1017\/S0950268811002184","article-title":"Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination","volume":"140","author":"Borr\u00e0s","year":"2012","journal-title":"Epidemiol Infect."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1128\/CVI.00247-09","article-title":"Maternal antibodies to pneumolysin but not to pneumococcal surface protein a delay early pneumococcal carriage in high-risk papua new guinean infants","volume":"16","author":"Francis","year":"2009","journal-title":"Clin Vaccine Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1016\/S0264-410X(03)00341-4","article-title":"Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life","volume":"21","author":"Gans","year":"2003","journal-title":"Vaccine."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/S0264-410X(00)00431-X","article-title":"Measles antibody responses after early two dose trials in guinea-bissau with edmonston-zagreb and schwarz standard-titre measles vaccine: better antibody increase from booster dose of the edmonston-zagreb vaccine","volume":"19","author":"Garly","year":"2001","journal-title":"Vaccine."},{"key":"B42","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1016\/j.vaccine.2008.09.014","article-title":"Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants","volume":"26","author":"Hu","year":"2008","journal-title":"Vaccine."},{"key":"B43","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.95.6.815","article-title":"Neonatal immunization: response to haemophilus influenzae type b-tetanus toxoid conjugate vaccine","volume":"95","author":"Kurikka","year":"1995","journal-title":"Pediatrics."},{"key":"B44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jpeds.2003.11.030","article-title":"Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants","volume":"144","author":"Letson","year":"2004","journal-title":"J Pediatr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/0264-410X(93)90255-V","article-title":"Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children","volume":"11","author":"Piedra","year":"1993","journal-title":"Vaccine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/archpedi.1985.02140120023021","article-title":"Antibody response of infants to two doses of inactivated poliovirus vaccine of enhanced potency","volume":"139","author":"Simoes","year":"1985","journal-title":"Am J Dis Children."},{"key":"B47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/1096-9071(200104)63:4<305::AID-JMV1006>3.0.CO;2-U","article-title":"Age- and dose-interval-dependent antibody responses to inactivated poliovirus vaccine","volume":"63","author":"Sormunen","year":"2001","journal-title":"J Med Virol."},{"key":"B48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1542\/peds.34.1.4","article-title":"The relationship of maternal antibody, breast feeding, and age to the susceptibility of newborn infants to infection with attenuated polioviruses","volume":"34","author":"Warren","year":"1964","journal-title":"Pediatrics."},{"key":"B49","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(88)92781-X","article-title":"Trial of high-dose edmonston-zagreb measles vaccine in the gambia: antibody response and side-effects","volume":"332","author":"Whittle","year":"1988","journal-title":"Lancet."},{"key":"B50","unstructured":"About Cytomegalovirus and Congenital CMV Infection.2019"},{"key":"B51","unstructured":"Newborn Screening.2019"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1056\/NEJMoa1006561","article-title":"Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns","volume":"364","author":"Boppana","year":"2011","journal-title":"N Engl J Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/INF.0000000000000609","article-title":"National Institute on Deafness and Other Communication Disorders CMV and hearing multicenter screening (CHIMES) study. Comparison of saliva PCR assay versus rapid culture for detection of congenital cytomegalovirus infection","volume":"34","author":"Pinninti","year":"2015","journal-title":"Pediatr Infect Dis J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/bdra.23601","article-title":"Cytomegalovirus infection in pregnancy","volume":"109","author":"Davis","year":"2017","journal-title":"Birth Defects Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J Pathol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1471-0528.2003.01302.x","article-title":"Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection","volume":"110","author":"Nigro","year":"2003","journal-title":"BJOG"},{"key":"B58","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/jwh.2006.15.224","article-title":"The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the centers for disease control and prevention workgroup","volume":"15","author":"Ross","year":"2006","journal-title":"J Women's Health."},{"key":"B60","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N Engl J Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jcv.2005.09.015","article-title":"Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome","volume":"35","author":"Pass","year":"2006","journal-title":"J Clin Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, clinical outcome","volume":"256","author":"Stagno","year":"1986","journal-title":"JAMA."},{"key":"B63","doi-asserted-by":"publisher","first-page":"B5","DOI":"10.1016\/j.ajog.2016.02.042","article-title":"Diagnosis and antenatal management of congenital cytomegalovirus infection","volume":"214","author":"Hughes","year":"2016","journal-title":"Am J Obset Gynecol"},{"key":"B64","first-page":"1","article-title":"Human cytomegalovirus (HCMV) infection\/re-infection: development of a protective HCMV vaccine","volume":"42","author":"Gerna","year":"2019","journal-title":"New Microbiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1093\/cid\/ciq085","article-title":"Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection","volume":"52","author":"Wang","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ajog.2009.11.018","article-title":"Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population","volume":"202","author":"Yamamoto","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"B67","unstructured":"2019"},{"key":"B68","first-page":"136","article-title":"Cytomegalovirus infections in transplant patients: methods of prevention of primary cytomegalovirus","volume":"23","author":"Bowden","year":"1991","journal-title":"Transpl Proc."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1542\/peds.2005-1142","article-title":"Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity","volume":"118","author":"Fowler","year":"2006","journal-title":"Pediatrics."},{"key":"B70","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/infdis\/132.4.472","article-title":"Cytomegalovirus in semen: observations in selected populations","volume":"132","author":"Lang","year":"1975","journal-title":"J Infect Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM197307052890101","article-title":"Maternal cytomegalovirus excretion and perinatal infection","volume":"289","author":"Reynolds","year":"1973","journal-title":"N Engl J Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0029-7844(98)00538-9","article-title":"Increased risk of cytomegalovirus transmission in utero during late gestation","volume":"93","author":"Bod\u00e9us","year":"1999","journal-title":"Obstet Gynecol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jcv.2009.11.009","article-title":"Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions","volume":"47","author":"Bod\u00e9us","year":"2010","journal-title":"J Clin Virol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1471-0528.2004.00328.x","article-title":"Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease","volume":"112","author":"Daiminger","year":"2005","journal-title":"BJOG"},{"key":"B75","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jcv.2011.07.005","article-title":"Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age","volume":"52","author":"Enders","year":"2011","journal-title":"J Clin Virol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1471-0528.1984.tb05915.x","article-title":"A prospective study of primary cytomegalovirus infection during pregnancy: final report","volume":"91","author":"Griffiths","year":"1984","journal-title":"BJOG."},{"key":"B77","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/pd.4118","article-title":"A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome","volume":"33","author":"Picone","year":"2013","journal-title":"Prenat Diagn."},{"key":"B78","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1128\/CMR.15.4.680-715.2002","article-title":"Diagnosis and management of human cytomegalovirus infection in the mother, fetus, newborn infant","volume":"15","author":"Revello","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"B79","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1471-0528.2007.01651.x","article-title":"Congenital cytomegalovirus infection following primary maternal infection in the third trimester","volume":"115","author":"Gindes","year":"2008","journal-title":"BJOG."},{"key":"B80","volume-title":"Vaccines for the 21st Century: A Tool for Decision Making","year":"2000"},{"key":"B81","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ajog.2007.09.052","article-title":"Ultrasound prediction of symptomatic congenital cytomegalovirus infection","volume":"198","author":"Guerra","year":"2008","journal-title":"Am J Obstet Gynecol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/pd.4340","article-title":"Detailed in utero ultrasound description of 30 cases of congenital cytomegalovirus infection","volume":"34","author":"Picone","year":"2014","journal-title":"Prenat Diagn."},{"key":"B83","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jcv.2007.10.015","article-title":"New advances in the diagnosis of congenital cytomegalovirus infection","volume":"41","author":"Lazzarotto","year":"2008","journal-title":"J Clin Virol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/pd.1970141108","article-title":"Accuracy of amniotic fluid testing before 21 weeks' gestation in prenatal diagnosis of congenital cytomegalovirus infection","volume":"14","author":"Donner","year":"1994","journal-title":"Prenat Diagn."},{"key":"B85","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/pd.59","article-title":"Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome","volume":"21","author":"Enders","year":"2001","journal-title":"Prenat Diagn."},{"key":"B86","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0029-7844(99)00657-2","article-title":"Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk","volume":"95","author":"Liesnard","year":"2000","journal-title":"Obstet Gynecol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1515\/jpm-2016-0287","article-title":"Utility of routine urine CMV PCR and total serum IgM testing of small for gestational age infants: a single center review","volume":"46","author":"Espiritu","year":"2018","journal-title":"J Perinat Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00431-017-3031-8","article-title":"Screening investigations in small-for-gestational-age near-term and term infants","volume":"176","author":"Krishnamurthy","year":"2017","journal-title":"Eur J Pediatr"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/INF.0000000000001763","article-title":"Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management","volume":"36","author":"Luck","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"B90","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000358867","article-title":"The C in TORCH: a cost-effective alternative to screening small-for-gestational-age infants","volume":"106","author":"Wei","year":"2014","journal-title":"Neonatology."},{"key":"B91","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1515\/jpm-2011-0257","article-title":"Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis","volume":"40","author":"Buxmann","year":"2012","journal-title":"J Perinat Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/infdis\/jir718","article-title":"Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy\u2013a case-control study of the outcome in children","volume":"205","author":"Nigro","year":"2012","journal-title":"J Infect Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N Engl J Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/cid\/cis423","article-title":"Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age","volume":"55","author":"Visentin","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N Engl J Med."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1030","article-title":"High-dose CMV hyperimmune globulin (HIG) and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary cytomegalovirus (CMV) infection","author":"Nigro","year":"2019","journal-title":"Clin Inf Dis"},{"key":"B97","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1542\/9781581109276-Cytomegalovirus","article-title":"Cytomegalovirus infection","volume-title":"Red Book: 2015 Report of the Committee on Infectious Diseases","author":"Kimberlin","year":"2015"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1097\/01.AOG.0000466430.19823.53","article-title":"Practice bulletin No. 151: cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"B99","unstructured":"Overview.2019"},{"key":"B100","first-page":"112","article-title":"Inbred guinea pig model of intrauterine infection with cytomegalovirus","volume":"122","author":"Griffith","year":"1986","journal-title":"Am J Pathol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2217\/fvl.10.8","article-title":"Guinea pig cytomegalovirus: a model for the prevention and treatment of maternal-fetal cytomegalovirus transmission","volume":"5","author":"Schleiss","year":"2010","journal-title":"Future Virol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-981-10-7230-7_13","article-title":"Vaccine development for cytomegalovirus","volume":"1045","author":"Inoue","year":"2018","journal-title":"Adv Exp Med Biol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e01442","DOI":"10.1128\/JVI.01442-19","article-title":"Inclusion of the viral pentamer complex in a vaccine design greatly improves protection against congenital cytomegalovirus in the guinea pig model","volume":"93","author":"Choi","year":"2019","journal-title":"J Virol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/vaccines7040182","article-title":"MVA-vectored pentameric complex (PC) and gB vaccines improve pregnancy outcome after guinea pig CMV challenge, but only gB vaccine reduces vertical transmission","volume":"7","author":"Contreras","year":"2019","journal-title":"Vaccines."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1016\/j.vaccine.2013.04.078","article-title":"Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta","volume":"31","author":"Hashimoto","year":"2013","journal-title":"Vaccine."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1016\/j.vaccine.2013.07.010","article-title":"Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model","volume":"32","author":"Schleiss","year":"2014","journal-title":"Vaccine."},{"key":"B107","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1016\/j.vaccine.2015.06.019","article-title":"Comparison of monovalent glycoprotein B with bivalent gB\/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality","volume":"33","author":"Swanson","year":"2015","journal-title":"Vaccine."},{"key":"B108","doi-asserted-by":"publisher","first-page":"13645","DOI":"10.1073\/pnas.1511526112","article-title":"Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission","volume":"112","author":"Bialas","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B109","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00430-007-0073-y","article-title":"Rhesus CMV: an emerging animal model for human CMV","volume":"197","author":"Powers","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e94002","DOI":"10.1172\/jci.insight.94002","article-title":"Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys","volume":"2","author":"Nelson","year":"2017","journal-title":"JCI Insight."},{"key":"B111","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.coviro.2017.08.005","article-title":"Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections","volume":"25","author":"Itell","year":"2017","journal-title":"Curr Opin Virol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/ars.2010.3241","article-title":"Nonhuman primate models of human immunology","volume":"14","author":"Messaoudi","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e00510","DOI":"10.1128\/CVI.00510-16","article-title":"Plasmablast response to primary rhesus cytomegalovirus (CMV) infection in a monkey model of congenital CMV transmission","volume":"24","author":"Fan","year":"2017","journal-title":"Clin Vaccine Immunol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"e00332","DOI":"10.1128\/mBio.00332-13","article-title":"Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein","volume":"4","author":"Wille","year":"2013","journal-title":"mBio."},{"key":"B115","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1469-0691.12449","article-title":"Cytomegalovirus vaccine: phase II clinical trial results","volume":"5","author":"Rieder","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"B116","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet."},{"key":"B118","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1073\/pnas.1800224115","article-title":"Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies","volume":"115","author":"Baraniak","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/infdis\/jiw487","article-title":"Maternal antibody responses and nonprimary congenital cytomegalovirus infection of HIV-1-exposed infants","volume":"214","author":"Bialas","year":"2016","journal-title":"J Infect Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/infdis\/171.5.1115","article-title":"Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection","volume":"171","author":"Boppana","year":"1995","journal-title":"J Infect Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s10875-012-9739-3","article-title":"Antibodies against neutralization epitopes of human cytomegalovirus gH\/gL\/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo","volume":"32","author":"Lilleri","year":"2012","journal-title":"J Clin Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"e59863","DOI":"10.1371\/journal.pone.0059863","article-title":"Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pUL128-130-131 complex during primary infection","volume":"8","author":"Lilleri","year":"2013","journal-title":"PLoS ONE."},{"key":"B123","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41541-018-0074-4","article-title":"A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection","volume":"3","author":"Nelson","year":"2018","journal-title":"NPJ Vaccines"},{"key":"B124","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B125","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/vaccines7030067","article-title":"The humoral immune response against the gB vaccine: lessons learnt from protection in solid organ transplantation","volume":"7","author":"Gomes","year":"2019","journal-title":"Vaccines."},{"key":"B126","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.humimm.2004.02.012","article-title":"Cytomegalovirus (CMV)-specific cellular immune responses","volume":"65","author":"Harari","year":"2004","journal-title":"Hum Immunol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.vaccine.2018.01.029","article-title":"Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity","volume":"36","author":"John","year":"2018","journal-title":"Vaccine"},{"key":"B128","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1086\/511982","article-title":"Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection","volume":"195","author":"Schleiss","year":"2007","journal-title":"J Infect Dis"},{"key":"B129","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3201\/eis1911.131226","article-title":"Cytomegaloviruses: from molecular pathogenesis to intervention","volume":"19","author":"Tang","year":"2013","journal-title":"Emerg Infect Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1093\/infdis\/jir138","article-title":"Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women","volume":"203","author":"Sabbaj","year":"2011","journal-title":"J Infect Dis."},{"key":"B132","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1093\/infdis\/jiz447","article-title":"The status of vaccine development against the human cytomegalovirus","volume":"221","author":"Plotkin","year":"2020","journal-title":"J Infect Dis"},{"key":"B133","doi-asserted-by":"publisher","first-page":"e00764","DOI":"10.1128\/JVI.00764-18","article-title":"Higher expectations for a vaccine to prevent congenital cytomegalovirus infection","volume":"92","author":"Gantt","year":"2018","journal-title":"J Virol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"e00771","DOI":"10.1128\/JVI.00771-18","article-title":"Higher expectations for a vaccine to prevent congenital cytomegalovirus infection","volume":"92","author":"Permar","year":"2018","journal-title":"J Virol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"e00030","DOI":"10.1128\/JVI.00030-18","article-title":"Advancing our understanding of protective maternal immunity as a guide for development of vaccines to reduce congenital cytomegalovirus infections","volume":"92","author":"Permar","year":"2018","journal-title":"J Virol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S2055-6640(20)30872-4","article-title":"Cytomegalovirus vaccines under clinical development","volume":"2","author":"Schleiss","year":"2016","journal-title":"J Virus Eradic."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e01695","DOI":"10.1128\/JVI.01695-18","article-title":"Intrahost dynamics of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees","volume":"93","author":"Nelson","year":"2019","journal-title":"J Virol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fped.2018.00027","article-title":"Group B streptococcal maternal colonization and neonatal disease: molecular mechanisms and preventative approaches","volume":"6","author":"Patras","year":"2018","journal-title":"Front Pediatr."},{"key":"B139","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal colonization with group b streptococcus and serotype distribution worldwide: systematic review and meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1093\/cid\/cix585","article-title":"Stillbirth with group B streptococcus disease worldwide: systematic review and meta-analyses","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B141","unstructured":"29398277Group B Streptococcus Vaccine Development Technology Roadmap2017"},{"key":"B142","doi-asserted-by":"publisher","first-page":"S190","DOI":"10.1093\/cid\/cix663","article-title":"Neurodevelopmental impairment in children after group B streptococcal disease worldwide: systematic review and meta-analyses","volume":"65","author":"Kohli-Lynch","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B143","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1542\/peds.2011-3453","article-title":"Long-term outcomes of group B streptococcal meningitis","volume":"130","author":"Libster","year":"2012","journal-title":"Pediatrics."},{"key":"B144","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","article-title":"Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance","volume":"173","author":"Nanduri","year":"2019","journal-title":"JAMA Pediatr."},{"key":"B145","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1128\/AAC.00461-08","article-title":"Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to \u03b2-lactam antibiotics","volume":"52","author":"Dahesh","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"B146","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1128\/AAC.00596-08","article-title":"Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility","volume":"52","author":"Nagano","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"B147","unstructured":"Prevention of Perinatal Group B Streptococcal Disease.2002"},{"key":"B148","year":"2017","journal-title":"WHO Preferred Product Characteristics for Group B Streptococcus Vaccines"},{"key":"B149","doi-asserted-by":"publisher","first-page":"360","DOI":"10.14740\/jocmr3809","article-title":"Prolonged rupture of membranes, neonatal outcomes and management guidelines","volume":"11","author":"Al-lawama","year":"2019","journal-title":"J Clin Med Res."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/INF.0000000000000439","article-title":"Factors associated with intrapartum transmission of group B streptococcus","volume":"33","author":"Berardi","year":"2014","journal-title":"Pediatr Infect Dis J."},{"key":"B151","year":"2018","journal-title":"Active Bacterial Core Surveillance Report Emerging Infections Program Network Group B Streptococcus"},{"key":"B152","doi-asserted-by":"publisher","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine","volume":"31","author":"Schrag","year":"2013","journal-title":"Vaccine."},{"key":"B153","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/archdischild-2016-311419","article-title":"Challenges in reducing group B streptococcus disease in African settings","volume":"102","author":"Nishihara","year":"2017","journal-title":"Arch Dis Child."},{"key":"B154","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1128\/IAI.32.1.56-61.1981","article-title":"Antibody to group B streptococcus type III in human sera measured by a mouse protection test","volume":"32","author":"Baltimore","year":"1981","journal-title":"Infect Immun."},{"key":"B155","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/infdis\/148.4.648","article-title":"Estimation of the protective level of human IgG antibody to the type-specific polysaccharide of group B streptococcus type Ia","volume":"148","author":"Klegerman","year":"1983","journal-title":"J Infect Dis."},{"key":"B156","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/infdis\/jit549","article-title":"Maternal antibody at delivery protects neonates from early onset group B streptococcal disease","volume":"209","author":"Baker","year":"2014","journal-title":"J Infect Dis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"6793","DOI":"10.1016\/j.vaccine.2015.10.019","article-title":"Correlates of protection of serotype-specific capsular antibody and invasive group B streptococcus disease in South African infants","volume":"33","author":"Dangor","year":"2015","journal-title":"Vaccine."},{"key":"B158","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/cid\/ciw377","article-title":"The protective value of maternal group B streptococcus antibodies: quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in european maternal sera","volume":"63","author":"Fabbrini","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1086\/323350","article-title":"Level of maternal antibody required to protect neonates against early-onset disease caused by group B streptococcus type Ia: a multicenter, seroepidemiology study","volume":"184","author":"Lin","year":"2001","journal-title":"J Infect Dis."},{"key":"B160","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1086\/422756","article-title":"Level of maternal IgG anti\u2013group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen","volume":"190","author":"Lin","year":"2004","journal-title":"J Infect Dis."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1016\/S1473-3099(18)30659-5","article-title":"Serocorrelates of protection against infant group B streptococcus disease","volume":"19","author":"Le Doare","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/infdis\/jiw056","article-title":"Serotype-specific cell-mediated immunity associated with clearance of homotypic group B streptococcus rectovaginal colonization in pregnant women","volume":"213","author":"Kwatra","year":"2016","journal-title":"J Infect Dis."},{"key":"B163","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0002-9378(99)70305-4","article-title":"A randomized trial of conjugated group B streptococcal type Ia vaccine in a rabbit model of ascending infection","volume":"181","author":"Davies","year":"1999","journal-title":"Am J Obstet Gynecol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1172\/JCI117319","article-title":"Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes","volume":"94","author":"Madoff","year":"1994","journal-title":"J Clin Invest."},{"key":"B165","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1086\/315285","article-title":"Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate","volume":"181","author":"Paoletti","year":"2000","journal-title":"J Infect Dis."},{"key":"B166","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B167","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1086\/314574","article-title":"Safety and immunogenicity of capsular polysaccharide\u2013tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib","volume":"179","author":"Baker","year":"1999","journal-title":"J Infect Dis."},{"key":"B168","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1086\/375536","article-title":"Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III","volume":"188","author":"Baker","year":"2003","journal-title":"J Infect Dis"},{"key":"B169","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1016\/S0264-410X(03)00353-0","article-title":"Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine","volume":"21","author":"Baker","year":"2003","journal-title":"Vaccine."},{"key":"B170","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1016\/j.vaccine.2012.04.048","article-title":"Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines","volume":"30","author":"Edwards","year":"2012","journal-title":"Vaccine."},{"key":"B171","doi-asserted-by":"publisher","first-page":"F403","DOI":"10.1136\/adc.2005.090472","article-title":"Association between low concentrations of antibodies to protein \u03b1 and Rib and invasive neonatal group B streptococcal infection","volume":"91","author":"Larsson","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B172","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1016\/j.vaccine.2019.04.039","article-title":"The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations","volume":"37","author":"Vekemans","year":"2019","journal-title":"Vaccine"},{"key":"B173","first-page":"1","author":"McQuillan","year":"2018","journal-title":"Prevalence of Herpes Simplex Virus Type 1 and Type 2 in Persons Aged 14-49: United States, 2015-2016"},{"key":"B174","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/GRF.0b013e31827146a7","article-title":"Neonatal herpes simplex virus infection","volume":"55","author":"Cherpes","year":"2005","journal-title":"Herpes Simplex Viruses."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1056\/NEJMra0807633","article-title":"Current concepts: maternal neonatal herpes simplex virus infections","volume":"361","author":"Corey","year":"2009","journal-title":"N Engl J Med."},{"key":"B176","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/j.semperi.2007.01.003","article-title":"Herpes simplex virus infections of the newborn","volume":"31","author":"Kimberlin","year":"2007","journal-title":"Semin Perinatol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/jama.289.2.203","article-title":"Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant","volume":"289","author":"Brown","year":"2003","journal-title":"J Am Med Assoc."},{"key":"B178","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/bdra.20013","article-title":"Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry. 1984-1999","volume":"70","author":"Stone","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1067\/mob.2003.185","article-title":"A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery","volume":"188","author":"Watts","year":"2003","journal-title":"Am J Obstet Gynecol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"369172","DOI":"10.1155\/2013\/369172","article-title":"The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention","volume":"2013","author":"Gantt","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1097\/00006250-200312000-00030","article-title":"Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review","volume":"102","author":"Sheffield","year":"2003","journal-title":"Obstet Gynecol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jpids\/piu050","article-title":"Mother-to-child transmission of herpes simplex virus","volume":"3","author":"James","year":"2014","journal-title":"J Pediatr Infect Dis Soc."},{"key":"B183","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1542\/peds.108.2.230","article-title":"Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections","volume":"108","author":"Kimberlin","year":"2001","journal-title":"Pediatrics."},{"key":"B184","doi-asserted-by":"publisher","first-page":"F483","DOI":"10.1136\/fn.88.6.F483","article-title":"Relapse of neonatal herpes simplex virus infection","volume":"88","author":"Kimura","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B185","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1651-2227.1991.tb11838.x","article-title":"A follow-up study of children with neonatal herpes simplex virus infections with particular regard to late nervous disturbances","volume":"80","author":"Malm","year":"1991","journal-title":"Acta Paediatr."},{"key":"B186","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJM199102143240704","article-title":"Predictors of morbidity and mortality in neonates with herpes simplex virus infections","volume":"324","author":"Whitley","year":"1991","journal-title":"N Engl J Med."},{"key":"B187","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1006\/viro.2000.0298","article-title":"Immune protection against HSV-2 in B-cell-deficient mice","volume":"270","author":"Dudley","year":"2000","journal-title":"Virology."},{"key":"B188","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1099\/0022-1317-82-4-845","article-title":"Differential roles of B cells and IFN-\u03b3-secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice","volume":"82","author":"Eriksson","year":"2001","journal-title":"J Gen Virol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"10587","DOI":"10.1128\/JVI.01237-12","article-title":"An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection","volume":"86","author":"Peng","year":"2012","journal-title":"J Virol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/infdis\/jiz521","article-title":"Murine model of maternal immunization demonstrates protective role for antibodies that mediate antibody-dependent cellular cytotoxicity in protecting neonates from herpes simplex virus type 1 and type 2","volume":"221","author":"Kao","year":"2019","journal-title":"J Infect Dis."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1086\/515286","article-title":"Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization","volume":"177","author":"Gallichan","year":"1998","journal-title":"J Infect Dis."},{"key":"B192","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0042-6822(95)80038-7","article-title":"Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract","volume":"206","author":"Milligan","year":"1995","journal-title":"Virology."},{"key":"B193","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/infdis\/jix628","article-title":"A herpes simplex virus (HSV)-2 single-cycle candidate vaccine deleted in glycoprotein D protects male mice from lethal skin challenge with clinical isolates of HSV-1 and HSV-2","volume":"217","author":"Burn","year":"2018","journal-title":"J Infect Dis."},{"key":"B194","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev.med.59.061606.095540","article-title":"Herpes simplex: insights on pathogenesis and possible vaccines","volume":"59","author":"Koelle","year":"2008","journal-title":"Annu Rev Med."},{"key":"B195","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41541-019-0129-1","article-title":"Successful application of prime and pull strategy for a therapeutic HSV vaccine","volume":"4","author":"Bernstein","year":"2019","journal-title":"NPJ Vaccines."},{"key":"B196","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature11522","article-title":"A vaccine strategy that protects against genital herpes by establishing local memory T cells","volume":"491","author":"Shin","year":"2012","journal-title":"Nature."},{"key":"B197","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1016\/j.vaccine.2011.06.083","article-title":"Of mice and not humans: How reliable are animal models for evaluation of herpes CD8 +-T cell-epitopes-based immunotherapeutic vaccine candidates?","volume":"29","author":"Dasgupta","year":"2011","journal-title":"Vaccine."},{"key":"B198","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fimmu.2019.00373","article-title":"Mechanisms of immune control of mucosal HSV infection: a guide to rational vaccine design","volume":"10","author":"Truong","year":"2019","journal-title":"Front Immunol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"Belshe","year":"2012","journal-title":"N Engl J Med."},{"key":"B200","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/infdis\/jit651","article-title":"Correlate of immune protection against HSV-1 genital disease in vaccinated women","volume":"209","author":"Belshe","year":"2014","journal-title":"J Infect Dis."},{"key":"B201","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.282.4.331","article-title":"Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials","volume":"282","author":"Corey","year":"1999","journal-title":"J Am Med Assoc."},{"key":"B202","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/infdis\/jiz225","article-title":"A randomized, double-blinded, placebo-controlled, phase 1 study of a replication-defective herpes simplex virus (HSV) type 2 vaccine, HSV529, in adults with or without HSV infection","volume":"220","author":"Dropulic","year":"2019","journal-title":"J Infect Dis."},{"key":"B203","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1080\/21645515.2016.1221872","article-title":"An escalating dose study to assess the safety, tolerability and immunogenicity of a herpes simplex virus DNA vaccine, COR-1","volume":"12","author":"Dutton","year":"2016","journal-title":"Hum Vaccines Immunother."},{"key":"B204","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1128\/JVI.01130-14","article-title":"Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes","volume":"88","author":"Awasthi","year":"2014","journal-title":"J Virol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.vaccine.2015.10.137","article-title":"A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs","volume":"34","author":"Odegard","year":"2016","journal-title":"Vaccine."},{"key":"B206","unstructured":"Global HIV and AIDS Statistics \u2014 2019 Fact Sheet.2019"},{"key":"B207","unstructured":"2019"},{"key":"B208","doi-asserted-by":"publisher","first-page":"18600","DOI":"10.7448\/IAS.16.1.18600","article-title":"Metabolic complications and treatment of perinatally HIV-infected children and adolescents","volume":"16","author":"Barlow-Mosha","year":"2013","journal-title":"J Int AIDS Soc."},{"key":"B209","unstructured":"27490260Consolidated Guidelines on HIV Testing Services For a Changing Epidemic.2019"},{"key":"B210","unstructured":"GenevaWorld Health OrganizationConsolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection2016"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trstmh.2005.05.012","article-title":"Current issues in the prevention of mother-to-child transmission of HIV-1 infection","volume":"100","author":"Newell","year":"2006","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B212","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1172\/JCI81593","article-title":"Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission","volume":"125","author":"Permar","year":"2015","journal-title":"J Clin Invest."},{"key":"B213","doi-asserted-by":"publisher","first-page":"e00062","DOI":"10.1128\/CVI.00062-17","article-title":"Maternal humoral immune correlates of peripartum transmission of clade C HIV-1 in the setting of peripartum antiretrovirals","volume":"24","author":"Mutucumarana","year":"2017","journal-title":"Clin Vaccine Immunol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1128\/JVI.06359-11","article-title":"Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection","volume":"86","author":"Diomede","year":"2012","journal-title":"J Virol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"e00716","DOI":"10.1128\/mSphere.00716-19","article-title":"Maternal humoral immune responses do not predict postnatal HIV-1 transmission risk in antiretroviral-treated mothers from the IMPAACT PROMISE study","volume":"4","author":"Hompe","year":"2019","journal-title":"MSphere."},{"key":"B216","doi-asserted-by":"publisher","first-page":"e1002739","DOI":"10.1371\/journal.ppat.1002739","article-title":"HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads","volume":"8","author":"Mabuka","year":"2012","journal-title":"PLoS Pathog."},{"key":"B217","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1128\/JVI.69.2.1001-1012.1995","article-title":"Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission","volume":"69","author":"Ahmad","year":"1995","journal-title":"J Virol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"e1006944","DOI":"10.1371\/journal.ppat.1006944","article-title":"Infant transmitted\/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma","volume":"14","author":"Kumar","year":"2018","journal-title":"PLoS Pathog."},{"key":"B219","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1128\/JVI.80.2.835-844.2006","article-title":"Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant","volume":"80","author":"Wu","year":"2006","journal-title":"J Virol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"e01373","DOI":"10.1128\/mBio.01373-17","article-title":"Maternal but not infant anti-HIV-1 neutralizing antibody response associates with enhanced transmission and infant morbidity","volume":"8","author":"Ghulam-Smith","year":"2017","journal-title":"mBio."},{"key":"B221","doi-asserted-by":"publisher","first-page":"e00176","DOI":"10.2139\/ssrn.3381953","article-title":"Maternal broadly neutralizing antibodies can select for neutralization-resistant, infant-transmitted\/founder HIV variants","volume":"11","author":"Martinez","year":"2020","journal-title":"mBio."},{"key":"B222","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1086\/515270","article-title":"Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection","volume":"177","author":"Van Rompay","year":"1998","journal-title":"J Infect Dis."},{"key":"B223","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/72309","article-title":"Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection","volume":"6","author":"Baba","year":"2000","journal-title":"Nat Med."},{"key":"B224","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nm.4063","article-title":"Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques","volume":"22","author":"Hessell","year":"2016","journal-title":"Nat Med."},{"key":"B225","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/QAI.0b013e31822f8914","article-title":"Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB\/NVP STUDY)","volume":"58","author":"Onyango-Makumbi","year":"2011","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B226","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1086\/314637","article-title":"Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS clinical trials group protocol 185","volume":"179","author":"Stiehm","year":"1999","journal-title":"J Infect Dis."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1086\/314985","article-title":"Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women","volume":"180","author":"Wright","year":"1999","journal-title":"J Infect Dis."},{"key":"B228","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.coi.2018.04.025","article-title":"Strategies for a multi-stage neutralizing antibody-based HIV vaccine","volume":"53","author":"Andrabi","year":"2018","journal-title":"Curr Opin Immunol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"e00878","DOI":"10.1128\/JVI.00878-18","article-title":"HIV-1 subtype C-infected children with exceptional neutralization breadth exhibit polyclonal responses targeting known epitopes","volume":"92","author":"Ditse","year":"2018","journal-title":"J Virol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.vaccine.2019.11.011","article-title":"Immunological mechanisms of inducing HIV immunity in infants","volume":"38","author":"Fouda","year":"2020","journal-title":"In Vaccine."},{"key":"B231","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nm.3565","article-title":"Early development of broadly neutralizing antibodies in HIV-1-infected infants","volume":"20","author":"Goo","year":"2014","journal-title":"Nat Med."},{"key":"B232","doi-asserted-by":"publisher","first-page":"358ra125","DOI":"10.1126\/scitranslmed.aag1048","article-title":"Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection","volume":"8","author":"Muenchhoff","year":"2016","journal-title":"Sci Transl Med."},{"key":"B233","unstructured":"Experimental HIV Vaccine Regimen Ineffective in Preventing HIV2019"},{"key":"B234","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet."},{"key":"B235","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev."},{"key":"B236","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1128\/MMBR.64.3.607-623.2000","article-title":"Lytic cycle of Toxoplasma gondii","volume":"64","author":"Black","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"key":"B237","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3109\/00365548.2012.693197","article-title":"A review on human toxoplasmosis","volume":"44","author":"Saadatnia","year":"2012","journal-title":"Scand J Infect Dis."},{"key":"B238","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/bmj.321.7254.142","article-title":"Sources of toxoplasma infection in pregnant women: European multicentre case-control study","volume":"321","author":"Cook","year":"2000","journal-title":"BMJ"},{"key":"B239","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"B240","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/590149","article-title":"Management of Toxoplasma gondii infection during pregnancy","volume":"47","author":"Montoya","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B241","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nri3598","article-title":"Innate immunity to Toxoplasma gondii infection","volume":"14","author":"Yarovinsky","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B242","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis1","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin Immunopathol."},{"key":"B243","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4049\/jimmunol.177.1.31","article-title":"Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice","volume":"177","author":"Aliberti","year":"2006","journal-title":"J Immunol"},{"key":"B244","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","article-title":"Toxoplasmic encephalitis in AIDS","volume":"15","author":"Luft","year":"1992","journal-title":"Clin Infect Dis"},{"key":"B245","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1128\/IAI.70.1.185-191.2002","article-title":"Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice","volume":"70","author":"Johnson","year":"2002","journal-title":"Infect Immun."},{"key":"B246","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/B978-0-12-802174-3.00017-5","article-title":"Vaccines against parasites","volume-title":"The Vaccine Book","author":"Sacks","year":"2016"},{"key":"B247","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.pt.2010.06.004","article-title":"Immunogenetics of toxoplasma gondii informs vaccine design","volume":"26","author":"Henriquez","year":"2010","journal-title":"Trends Parasitol"},{"key":"B248","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2334-14-33","article-title":"Congenital toxoplasmosis and prenatal care state programs","volume":"14","author":"Avelino","year":"2014","journal-title":"BMC Infect Dis"},{"key":"B249","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","article-title":"Advances in the development of anti-Toxoplasma gondii vaccines: challenges, opportunities, and perspectives","volume":"35","author":"Wang","year":"2019","journal-title":"Trends Parasitol."},{"key":"B250","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.vetpar.2011.05.036","article-title":"Developing vaccines to control protozoan parasites in ruminants: dead or alive?","volume":"180","author":"Innes","year":"2011","journal-title":"Vet Parasitol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/00128325.2015.1040646","article-title":"Adoption of east coast fever vaccine among smallholder dairy farmers in kenya: the case of North Rift Kenya","volume":"81","author":"Karanja-Lumumba","year":"2015","journal-title":"East Afr Agric For J."},{"key":"B252","doi-asserted-by":"publisher","first-page":"E525","DOI":"10.1016\/S2214-109X(16)30135-8","article-title":"Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study","volume":"4","author":"Wijesooriya","year":"2016","journal-title":"Lancet Global Health"},{"key":"B253","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/AAC.01095-09","article-title":"Global challenge of antibiotic-resistant Treponema pallidum","volume":"54","author":"Stamm","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"B254","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1001\/jama.2019.17031","article-title":"Ending congenital syphilis","volume":"322","author":"Stafford","year":"2019","journal-title":"JAMA"},{"key":"B255","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1097\/OLQ.0000000000000831","article-title":"Syphilis vaccine development: requirements, challenges and opportunities","volume":"45","author":"Cameron","year":"2018","journal-title":"Sex Transm Dis"},{"key":"B256","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jama.2018.20843","article-title":"Why are mothers still passing syphilis to their babies?","volume":"321","author":"Rubin","year":"2019","journal-title":"JAMA"},{"key":"B257","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s10995-018-2592-0","article-title":"State requirements for prenatal syphilis screening in the United States, 2016","volume":"22","author":"Warren","year":"2018","journal-title":"Matern Child Health J."},{"key":"B258","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s40471-018-0138-z","article-title":"An update on the global epidemiology of syphilis","volume":"5","author":"Kojima","year":"2018","journal-title":"Curr Epidemiol Rep."},{"key":"B259","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/ped.14132","article-title":"Gaps to eliminate congenital syphilis in a tertiary care center in Thailand","volume":"62","author":"Anugulruengkitt","year":"2019","journal-title":"Pediatr Int."},{"key":"B260","doi-asserted-by":"publisher","first-page":"e0159483","DOI":"10.1371\/journal.pone.0159483","article-title":"Estimating benzathine penicillin need for the treatment of pregnant women diagnosed with syphilis during antenatal care in high-morbidity countries","volume":"11","author":"Taylor","year":"2016","journal-title":"PLoS ONE."},{"key":"B261","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nrmicro.2016.141","article-title":"Treponema pallidum, the syphilis spirochete: making a living as a stealth pathogen HHS public access","volume":"14","author":"Radolf","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"B262","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4049\/jimmunol.124.1.454","article-title":"Characterization of lymphocyte responsiveness in early experimental syphilis. I. In vitro response to mitogens and Treponema pallidum antigens","volume":"124","author":"Lukehart","year":"1980","journal-title":"J Immunol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/DAD.0b013e3181e8b587","article-title":"THE immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity","volume":"33","author":"Carlson","year":"2011","journal-title":"Am J Dermatopathol."},{"key":"B264","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1086\/315399","article-title":"Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92","volume":"181","author":"Cameron","year":"2000","journal-title":"J Infect Dis."},{"key":"B265","doi-asserted-by":"publisher","first-page":"e01153","DOI":"10.1128\/mBio.01153-18","article-title":"Long-term in vitro culture of the syphilis spirochete Treponema pallidum subsp","volume":"9","author":"Edmondson","year":"2018","journal-title":"Pallidum MBio."},{"key":"B266","first-page":"627","article-title":"Zurich, world health organization","volume":"45","author":"Metzger","year":"1957","journal-title":"Acta Pathol Microbiol Scand."},{"key":"B267","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2017_44","article-title":"The Treponema pallidum outer membrane","volume":"415","author":"Radolf","year":"2018","journal-title":"Curr Top Microbiol Immunol."},{"key":"B268","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40409-017-0131-x","article-title":"Zika virus congenital syndrome: experimental models and clinical aspects","volume":"23","author":"Polonio","year":"2017","journal-title":"J Venom Anim Toxins Incl Trop Dis."},{"key":"B269","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","article-title":"Zika virus and birth defects \u2014 reviewing the evidence for causality","volume":"374","author":"Rasmussen","year":"2016","journal-title":"N Engl J Med"},{"key":"B270","doi-asserted-by":"publisher","first-page":"366","DOI":"10.15585\/mmwr.mm6613e1","article-title":"Vital signs: update on zika virus\u2013associated birth defects and evaluation of all U.S. infants with congenital zika virus exposure \u2014 U.S. zika pregnancy registry 2016","volume":"66","author":"Reynolds","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B271","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","article-title":"Zika virus infection in pregnant women in rio de janeiro","volume":"375","author":"Brasil","year":"2016","journal-title":"N Engl J Med."},{"key":"B272","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"374","author":"Mlakar","year":"2016","journal-title":"N Engl J Med."},{"key":"B273","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3201\/eid1705.101939","article-title":"Probable non-vector-borne transmission of zika virus, Colorado, USA","volume":"17","author":"Foy","year":"2011","journal-title":"Emerg Infect Dis."},{"key":"B274","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, federated states of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N Engl J Med."},{"key":"B275","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nm.4485","article-title":"Congenital zika virus infection as a silent pathology with loss of neurogenic output in the fetal brain","volume":"24","author":"Adams Waldorf","year":"2018","journal-title":"Nat Med."},{"key":"B276","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41591-019-0496-1","article-title":"Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children","volume":"25","author":"Nielsen-Saines","year":"2019","journal-title":"Nat Med."},{"key":"B277","unstructured":"Transcript for CDC Telebriefing: Zika Summit Press Conference2016"},{"key":"B278","doi-asserted-by":"publisher","first-page":"e00932","DOI":"10.1128\/mSphere.00392-16","article-title":"Seroprevalence of zika virus in wild African green monkeys and baboons","volume":"2","author":"Buechler","year":"2016","journal-title":"mSphere"},{"key":"B279","doi-asserted-by":"publisher","first-page":"e00523","DOI":"10.1128\/mSphere.00523-17","article-title":"Limited evidence for infection of urban and peri-urban nonhuman primates with zika and chikungunya viruses in Brazil","volume":"3","author":"Moreira-Soto","year":"2018","journal-title":"MSphere."},{"key":"B280","doi-asserted-by":"publisher","first-page":"16034","DOI":"10.1038\/s41598-018-34423-6","article-title":"Evidence of natural zika virus infection in neotropical non-human primates in Brazil","volume":"8","author":"Terzian","year":"2018","journal-title":"Sci Rep."},{"key":"B281","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1073\/pnas.1718476115","article-title":"Implications of zika virus and congenital zika syndrome for the number of live births in Brazil","volume":"115","author":"Castro","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B282","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2105\/AJPH.2017.304260","article-title":"Zika-associated microcephaly epidemic and birth rate reduction in Brazilian cities","volume":"108","author":"Diaz-Quijano","year":"2018","journal-title":"Am J Public Health."},{"key":"B283","doi-asserted-by":"publisher","first-page":"781","DOI":"10.15585\/mmwr.mm6629e1","article-title":"Update: interim guidance for health care providers caring for pregnant women with possible zika virus exposure \u2014 United States (including territories) US, July 2017","volume":"66","author":"Oduyebo","year":"2017","journal-title":"MMWR Morbi Mortal Wkly Rep."},{"key":"B284","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4269\/ajtmh.2012.11-0770","article-title":"Review: the history of dengue outbreaks in the Americas","volume":"87","author":"Dick","year":"2012","journal-title":"Am J Trop Med Hygiene."},{"key":"B285","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/cid\/ciy209","article-title":"Prolonged detection of zika virus nucleic acid among symptomatic pregnant women: a cohort study","volume":"67","author":"Lozier","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B286","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1056\/NEJMoa1613108","article-title":"Persistence of zika virus in body fluids \u2014 final report","volume":"379","author":"Paz-Bailey","year":"2018","journal-title":"N Engl J Med."},{"key":"B287","doi-asserted-by":"publisher","first-page":"870","DOI":"10.15585\/mmwr.mm6533e2","article-title":"Update: interim guidance for the evaluation and management of infants with possible congenital zika virus infection \u2014 United States, August 2016","volume":"65","author":"Russell","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B288","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/ppe.12478","article-title":"Breast milk transmission of flaviviruses in the context of zika virus: a systematic review","volume":"32","author":"Mann","year":"2018","journal-title":"Paediatr Perinatal Epidemiol."},{"key":"B289","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.1038\/ncomms12204","article-title":"A rhesus macaque model of Asian-lineage zika virus infection","volume":"7","author":"Dudley","year":"2016","journal-title":"Nat Commun."},{"key":"B290","doi-asserted-by":"publisher","first-page":"S919","DOI":"10.1093\/infdis\/jix465","article-title":"Small-animal models of zika virus","volume":"216","author":"Julander","year":"2017","journal-title":"J Infect Dis."},{"key":"B291","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.coviro.2018.03.004","article-title":"The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection","volume":"29","author":"Katzelnick","year":"2018","journal-title":"Curr Opin Virol."},{"key":"B292","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science."},{"key":"B293","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"B294","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41467-018-03337-2","article-title":"A systematic approach to the development of a safe live attenuated zika vaccine","volume":"9","author":"Kwek","year":"2018","journal-title":"Nat Commun."},{"key":"B295","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature."},{"key":"B296","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature."},{"key":"B297","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"6736","author":"Gaudinski","year":"2017","journal-title":"Lancet."},{"key":"B298","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41467-018-04056-4","article-title":"Fetal demise and failed antibody therapy during zika virus infection of pregnant macaques","volume":"9","author":"Magnani","year":"2018","journal-title":"Nat Commun."},{"key":"B299","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aay2736","article-title":"DNA vaccination before conception protects zika virus\u2013exposed pregnant macaques against prolonged viremia and improves fetal outcomes","volume":"11","author":"van Rompay","year":"2019","journal-title":"Sci Transl Med."},{"key":"B300","doi-asserted-by":"publisher","first-page":"e02861","DOI":"10.1128\/mBio.02861-18","article-title":"Antibodies elicited by an NS1-based vaccine protect mice against zika virus","volume":"10","author":"Bailey","year":"2019","journal-title":"MBio."},{"key":"B301","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1038\/s41467-018-07008-0","article-title":"Human antibodies targeting zika virus NS1 provide protection against disease in a mouse model","volume":"9","author":"Bailey","year":"2018","journal-title":"Nat Commun."},{"key":"B302","doi-asserted-by":"publisher","first-page":"e1006378","DOI":"10.1371\/journal.ppat.1006378","article-title":"Highly efficient maternal-fetal Zika virus transmission in pregnant rhesus macaques","volume":"13","author":"Nguyen","year":"2017","journal-title":"PLoS Pathog."},{"key":"B303","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41564-019-0618-z","article-title":"Evolution of the innate and adaptive immune response in women with acute zika virus infection","volume":"5","author":"Tonnerre","year":"2020","journal-title":"Nat Microbiol."},{"key":"B304","doi-asserted-by":"publisher","first-page":"ofy352","DOI":"10.1093\/ofid\/ofy352","article-title":"Clinical, virologic, and immunologic characteristics of zika virus infection in a cohort of US patients: prolonged RNA detection in whole blood","volume":"6","author":"El Sahly","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"B305","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/cells8080820","article-title":"Protective to a T: the role of T cells during zika virus infection","volume":"8","author":"Pardy","year":"2019","journal-title":"Cells."},{"key":"B306","doi-asserted-by":"publisher","first-page":"e0006000","DOI":"10.1371\/journal.pntd.0006000","article-title":"Ontogeny of the B- and T-cell response in a primary zika virus infection of a dengue-na\u00efve individual during the 2016 outbreak in Miami, FL","volume":"11","author":"Ricciardi","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"B307","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005168","article-title":"Heterologous protection against Asian zika virus challenge in rhesus macaques","volume":"10","author":"Aliota","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"B308","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.celrep.2016.07.049","article-title":"Broadly neutralizing activity of zika virus-immune sera identifies a single viral serotype","volume":"16","author":"Dowd","year":"2016","journal-title":"Cell Rep"},{"key":"B309","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2016.03.008","article-title":"Type III interferons produced by human placental trophoblasts confer protection against zika virus infection","volume":"19","author":"Bayer","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B310","doi-asserted-by":"publisher","first-page":"eaao1680","DOI":"10.1126\/sciimmunol.aao1680","article-title":"Type I interferons instigate fetal demise after zika virus infection","volume":"3","author":"Yockey","year":"2018","journal-title":"Sci Immunol."},{"key":"B311","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molimm.2015.02.030","article-title":"The complement system and adverse pregnancy outcomes","volume":"67","author":"Regal","year":"2015","journal-title":"Mol Immunol."},{"key":"B312","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/14767050500072722","article-title":"Normal pregnancy is characterized by systemic activation of the complement system","volume":"17","author":"Richani","year":"2005","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B313","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3389\/fimmu.2018.02177","article-title":"Active human complement reduces the zika virus load via formation of the membrane-attack complex","volume":"9","author":"Schiela","year":"2018","journal-title":"Front Immunol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science."},{"key":"B315","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science."},{"key":"B316","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol."},{"key":"B317","doi-asserted-by":"publisher","first-page":"7852","DOI":"10.1073\/pnas.1607931113","article-title":"Human antibody responses after dengue virus infection are highly cross-reactive to zika virus","volume":"113","author":"Priyamvada","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B318","doi-asserted-by":"publisher","first-page":"e1002726","DOI":"10.1371\/journal.pmed.1002726","article-title":"Prior dengue virus infection and risk of zika: a pediatric cohort in Nicaragua","volume":"16","author":"Gordon","year":"2019","journal-title":"PLoS Med."},{"key":"B319","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1126\/science.aav6618","article-title":"Impact of preexisting dengue immunity on zika virus emergence in a dengue endemic region","volume":"363","author":"Rodriguez-Barraquer","year":"2019","journal-title":"Science."},{"key":"B320","doi-asserted-by":"publisher","first-page":"e1006487","DOI":"10.1371\/journal.ppat.1006487","article-title":"Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques","volume":"13","author":"McCracken","year":"2017","journal-title":"PLoS Pathog."},{"key":"B321","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1038\/s41467-019-12295-2","article-title":"Time elapsed between zika and dengue virus infections affects antibody and T cell responses","volume":"10","author":"P\u00e9rez-Guzm\u00e1n","year":"2019","journal-title":"Nat Commun."},{"key":"B322","doi-asserted-by":"publisher","first-page":"e0007648","DOI":"10.1371\/journal.pntd.0007648","article-title":"Efficient transplacental IgG transfer in women infected with Zika virus during pregnancy","volume":"13","author":"Singh","year":"2019","journal-title":"PLoS Negl Trop Dis."},{"key":"B323","doi-asserted-by":"publisher","first-page":"eaat0360","DOI":"10.1126\/scitranslmed.aat0360","article-title":"Design of vaccine efficacy trials during public health emergencies","volume":"11","author":"Dean","year":"2019","journal-title":"Sci Transl Med."},{"key":"B324","doi-asserted-by":"publisher","first-page":"432","DOI":"10.2105\/AJPH.2015.302996","article-title":"Ethical rationale for the ebola \u201cring vaccination\u201d trial design","volume":"106","author":"Rid","year":"2016","journal-title":"Am J Public Health"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.00569\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T09:19:39Z","timestamp":1697534379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.00569\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":324,"alternative-id":["10.3389\/fped.2020.00569"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.00569","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]},"article-number":"569"}}